Jannik Pallisgaard
Overview
Explore the profile of Jannik Pallisgaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tonnesen J, Ruwald M, Pallisgaard J, Rasmussen P, Johannessen A, Hansen J, et al.
J Am Heart Assoc
. 2024 Mar;
13(7):e032722.
PMID: 38533962
Background: Guidelines recommend prioritizing treatment with antiarrhythmic drugs before referral of patients with atrial fibrillation to ablation, delaying a potential subsequent ablation. However, delaying ablation may affect ablation outcomes. We...
2.
Zorner C, Pallisgaard J, Schjerning A, Jensen M, Tonnesen J, Riis-Vestergaard L, et al.
BMJ Open
. 2023 Sep;
13(9):e074010.
PMID: 37666552
Objectives: To describe the population of patients diagnosed with hypertrophic cardiomyopathy (HCM) in Denmark and determine temporal trends in incidence and patient characteristics over time. Design: Nationwide retrospective cohort study....
3.
Tonnesen J, Pallisgaard J, Rasmussen P, Ruwald M, Lamberts M, Nouhravesh N, et al.
BMJ Open
. 2023 Jan;
13(1):e062768.
PMID: 36657765
Aims: Cancer is a well-known risk factor of venous thromboembolism (VTE). Some cancers are believed to be more thrombogenic. The purpose of this study was to investigate the characteristics of...
4.
Tonnesen J, Pallisgaard J, Ruwald M, Rasmussen P, Johannessen A, Hansen J, et al.
Europace
. 2022 Dec;
25(2):425-432.
PMID: 36480430
Aims: Overweight is associated with increased risk of atrial fibrillation (AF), but the impact of overweight and AF recurrence after ablation is less clear. Despite this, an increasing number of...
5.
Pallisgaard J, Greve A, Lock-Hansen M, Thune J, Fosboel E, Devereux R, et al.
Europace
. 2022 Nov;
25(2):283-290.
PMID: 36349557
Aims: Atrial fibrillation (AF) and heart failure (HF) often coexist. However, whether AF onset before HF or vice versa is associated with the worst outcome remains unclear. A consensus of...
6.
Polcwiartek C, Krogager M, Andersen M, Butt J, Pallisgaard J, Fosbol E, et al.
Am Heart J Plus
. 2022 Apr;
14:100131.
PMID: 35463196
Background: Although troponin elevation is associated with worse outcomes among patients with coronavirus disease 2019 (COVID-19), prognostic implications of serial troponin testing are lacking. We investigated the association between serial...
7.
Skaarup K, Lassen M, Espersen C, Lind J, Johansen N, Sengelov M, et al.
J Ultrasound
. 2021 Jul;
25(3):457-467.
PMID: 34213740
Purpose: Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and...
8.
Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study
Hodges G, Pallisgaard J, Olsen A, McGettigan P, Andersen M, Krogager M, et al.
BMJ Open
. 2020 Dec;
10(12):e041295.
PMID: 33268425
Objective: To evaluate the association between common biomarkers, death and intensive care unit (ICU) admission in patients with COVID-19. Design: Retrospective cohort study. From electronic national registry data, we used...
9.
Skaarup K, Lassen M, Lind J, Alhakak A, Sengelov M, Nielsen A, et al.
JACC Cardiovasc Imaging
. 2020 Sep;
13(11):2474-2476.
PMID: 32994145
No abstract available.
10.
Kragholm K, Gerds T, Fosbol E, Andersen M, Phelps M, Butt J, et al.
Clin Transl Sci
. 2020 Sep;
13(6):1103-1107.
PMID: 32970921
Recommendations regarding ibuprofen use in relation to coronavirus disease 2019 (COVID-19) have been conflicting. We examined the risk of severe COVID-19 between ibuprofen-prescribed and non-ibuprofen patients with COVID-19 in a...